The University of Manitoba is proud to announce an impressive four new Fellows elected to The Canadian Academy of Health Sciences (CAHS) for 2022. The CAHS Fellowship recognizes excellence in health sciences and these 71 new Fellows across Canada reflect a rich and varied expertise.
The Canadian Academy of Health Sciences brings together Canada’s top-ranked health and biomedical scientists and scholars who make a positive impact on the urgent health concerns of Canadians. Election to Fellowship in the Academy is considered one of the highest honours for individuals in the Canadian health sciences community.
“The innovative research programs of these outstanding clinician-scientists have made indelible impacts on the lives of so many around the world,” says Dr. Digvir Jayas, vice-president (research and international) and Distinguished Professor at UM. “We congratulate them on this most deserved recognition for their decades of research into Canada’s most complex health challenges.”
Dr. Peter Nickerson, vice-provost (health sciences) and dean, Rady Faculty of Health Sciences, added, “We are honoured to congratulate our four faculty members on election to the Canadian Academy of Health Sciences. Their extensive and impactful research into global public health, Indigenous health, clinical research and infectious diseases has not only improved health locally, nationally and globally, but rightfully earned them this prestigious distinction.”
Dr. Bram Ramjiawan
Director of Clinical Research, Innovation and Regulatory Affairs and Director of Research, Asper Clinical Research Institute, St. Boniface Hospital and Research Centre
Dr. Bram Ramjiawan is responsible for the oversight of clinical research and to oversee and ensure that all clinical, regulatory and business issues are handled as required by national and international agencies. Dr. Ramjiawan is an International expert on clinical trials. He is resident internal reviewer for the European Union, various United States departments (FDA, NIH) and Canada.
Prior to joining the hospital, Dr. Ramjiawan worked with the Government of Canada (National Research Council) as an industrial technology advisor who specialized in life sciences and biomedical technologies. Dr. Ramjiawan is an adjunct professor of pharmacology and therapeutics, Max Rady College of Medicine, University of Manitoba.
He serves on many national and international organizations. At the national level Dr. Ramjiawan is on the steering committee of the Canadian Standards Association on Medical Technology and Health Care. At the international level, he is a reviewer for the United States National Institutes of Health and for the European Union Commission on Health Science and Ethics.
Dr. James Blanchard
Professor, Community Health Sciences, and Executive Director, Institute for Global Public Health, Rady Faculty of Health Sciences, University of Manitoba
Dr. James Blanchard is an epidemiologist and public health specialist focusing on global health. His research focuses on how the characteristics of individuals, communities and large populations contribute to the local and global distribution of communicable and non-communicable diseases.
Over the past 25 years, he has also provided leadership globally to applying research to improve the design and implementation of large public health programs related to sexually transmitted infections, HIV/AIDS and maternal, neonatal and child health focused in south Asia and Africa.
Dr. Blanchard has also contributed to the development of scientific knowledge about what creates epidemics of communicable and non-communicable diseases, and in the translation of that knowledge into effective programs and policies to improve health. Globally, he has advanced knowledge about the factors that generate HIV epidemics and translated that knowledge into high impact programs to control HIV in south Asia and Africa. In Canada, he has been a leader in developing methods to study the emerging epidemics of diabetes and inflammatory bowel disease.
He holds a Tier 1 Canada Research Chair in epidemiology and global public health.
Dr. Josée G. Lavoie
Professor, Community Health Sciences, Max Rady College of Medicine, and Director of Ongomiizwin -Research, Indigenous Institute of Health and Healing, Rady Faculty of Health Sciences, University of Manitoba
Dr. Josée G. Lavoie, a Fulbright scholar, is an internationally-renowned researcher who, for the past 30 years, has been working in partnership with Indigenous communities and organizations to improve Indigenous peoples’ access to responsive health services.
Dr. Lavoie’s program of research is uniquely positioned in partnership with First Nations, Inuit and other Indigenous groups across Canada, in Alaska, Norway, Colombia, Australia, New Zealand and circumpolar countries.
Her research focuses on improved access to primary health care for underserved and marginalized populations, in rural, remote and inner-city environments; and on shifting health policy.
Dr. Lavoie’s program of research demonstrates leadership in engaged scholarship. She is particularly interested in how western and Indigenous knowledge systems interface in the provision of health services in Indigenous communities. She maintains on-going partnerships with the First Nations Health and Social Secretariat of Manitoba and with the Manitoba Inuit Association. She is actively engaged in collaborations in Australia and New Zealand, and in circumpolar health research.
Dr. George Zhanel
Professor, Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba
Dr. George Zhanel is research director of the Canadian Antimicrobial Resistance Alliance (CARA) and the founding and chief editor of the Canadian Antimicrobial Resistance Alliance (CARA) website (www.can-r.com).
Dr. Zhanel has been involved in treatment guideline development for a variety of infectious diseases and studying antimicrobial usage/resistance in humans, animals and food and the impact of antimicrobial exposure on human and animal microbiomes.
He has published over 1,000 papers, chapters and abstracts in the areas of treatment and prevention of infectious diseases, pharmacokinetics/pharmacodynamics and discovery and development.
Dr. Zhanel has been involved in treatment guideline development for a variety of infectious diseases and is also interested in antimicrobial usage/resistance in humans, animals and food (one health) and the impact of antimicrobial exposure on human and animal microbiomes.
In 2020, he received the Canadian Association for Medical Education merit award, and in 2021, he was 1 of 190 Canadian scientists recognized as a “highly cited researcher”, an honour received by 1 out of 1000 of the world’s scientists.